Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 4—April 2025
Dispatch
Exposure of Wild Mammals to Influenza A(H5N1) Virus, Alaska, USA, 2020–2023
Figure 2

Figure 2. Inferred seropositivity among 124 samples collected from wild mammals, Alaska, USA, December 2021–September 2023, after detection of HPAI H5 clade 2.3.4.4b in North America, to influenza A antigens. Seropositivity to NP was determined using a blocking ELISA. Seropositivity to North American lineage LPAI H5 and HPAI H5 clade 2.3.4.4b were determined using virus microneutrialization. Seropositivity to N1 was determined using an enzyme-linked lectin assay. HPAI, highly pathogenic avian influenza; LPAI, low pathogenicity avian influenza; NP, nucleoprotein.
Page created: February 18, 2025
Page updated: March 13, 2025
Page reviewed: March 13, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.